Creative Biogene is a US-based biotechnology company at the forefront of life science research and drug discovery. They specialize in providing a comprehensive suite of high-quality products and sophisticated services, including custom gene synthesis, plasmid DNA manufacturing, viral vector construction and packaging (AAV, lentivirus, adenovirus), stable cell line development, advanced CRISPR/Cas9 gene editing, and services for mRNA vaccine and CAR-T cell therapy development. Creative Biogene is committed to empowering researchers and pharmaceutical partners worldwide by delivering reliable, tailored solutions to accelerate scientific innovation and the development of novel therapeutics.
The headquarters serves as the central nexus for Creative Biogene's core activities, including advanced research and development, custom biotechnology service provision, manufacturing of biological reagents and viral vectors, quality control, and corporate administration.
The facility is equipped with state-of-the-art laboratories designed for complex molecular biology, virology, cell culture, and genetic engineering workflows, adhering to high standards for research and production environments.
The work culture at Creative Biogene is characterized by a strong emphasis on scientific innovation, precision, and collaboration. Employees are part of a dynamic environment focused on solving complex biological challenges and delivering high-quality results for a global client base.
This headquarters is pivotal to Creative Biogene's operations, enabling the development and global distribution of its specialized biotech products and services. Its location provides access to a skilled scientific talent pool and a supportive biotech ecosystem.
Creative Biogene maintains a significant global presence by serving researchers, academic institutions, and biopharmaceutical companies across the world. While its primary research, development, and manufacturing facilities are centralized in the United States, the company effectively delivers its extensive portfolio of biotechnology products (such as custom genes, viral vectors, and engineered cell lines) and specialized services (including CRISPR editing and CAR-T development support) to an international customer base. This global outreach is supported by robust international shipping logistics, online service platforms, and a dedicated global customer support system, potentially augmented by regional distributors and representatives in key markets.
45-1 Ramsey Road
Shirley
NY
USA
Address: Primary operations and international support managed from 45-1 Ramsey Road, Shirley, NY, USA. Specific distinct international office addresses are not prominently listed.
To provide comprehensive sales, technical support, and project management to researchers and pharmaceutical companies across North America, Europe, Asia-Pacific, and other key international markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Creative Biogene' leadership includes:
Creative Biogene has been backed by several prominent investors over the years, including:
There has been no prominent public news regarding high-level executive hires or departures at Creative Biogene in the last 12 months. Personnel changes, if any, are likely managed internally without broad public announcements typical of larger or publicly-traded corporations.
Discover the tools Creative Biogene uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Creative Biogene's exact email format is not officially published. However, a common format for companies in the biotechnology sector is [first_initial][last]@[companydomain.com] or [first].[last]@[companydomain.com]. For general inquiries, the company provides specific contact addresses on its website.
[first].[last]@creative-biogene.com (e.g., john.doe@creative-biogene.com) or [first_initial][last]@creative-biogene.com (e.g., jdoe@creative-biogene.com)
Format
jane.doe@creative-biogene.com
Example
70%
Success rate
biospace.com • May 16, 2024
Creative Biogene announced its expanded comprehensive solutions for circular RNA (circRNA) research. These services include circRNA identification, characterization, functional analysis, and circRNA-based therapeutic development support, aiming to accelerate discoveries in this emerging field....more
news-medical.net • November 9, 2023
Creative Biogene has enhanced its Chimeric Antigen Receptor T-cell (CAR-T) therapy development solutions, offering comprehensive services from CAR design and construction to T-cell engineering and preclinical efficacy testing. This update aims to support the advancement of novel cancer immunotherapies....more
pharmiweb.com • August 1, 2023
Creative Biogene introduced new, innovative solutions for vaccine adjuvant development, providing researchers with a range of adjuvant screening, formulation, and evaluation services to help improve vaccine efficacy and immune response....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Creative Biogene, are just a search away.